VolitionRX

$3.45
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.05 (+1.47%) As of 6:17 PM UTC today

Why Robinhood?

You can buy or sell VolitionRX and other stocks, options, and ETFs commission-free!

About VNRX

VolitionRX Limited Common Stock, also called VolitionRX, is a multi-national life sciences company, which engages in the development of blood-based cancer tests to help diagnose a range of cancers. Its products include the Nucleosomics platform that identifies and measures nucleosomes in the bloodstream or other bodily fluid. The company was founded on August 5, 2010 and is headquartered in Austin, TX. The listed name for VNRX is VolitionRX Limited Common Stock.

CEO

Cameron John Reynolds

Employees

Headquarters

Austin, Texas

Founded

2010

Market Cap

166.28M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

126.02K

High Today

$3.50

Low Today

$3.37

Open Price

$3.41

Volume

126.53K

52 Week High

$5.30

52 Week Low

$2.22

Collections

Health

Cancer Prevention

North America

VNRX Earnings

-$0.14

-$0.09

-$0.05

$0.00

Q1 FY19

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Estimated

— per share

Actual

Expected Feb 18, After Hours